In the long battle against cancer, human beings have moved from chemotherapy and radiation to targeted drugs, and now to cell-based therapies.Among these innovations, CAR-T cell ...
The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...